{"title":"原发性脑出血:自然史、预后和结局","authors":"Renee B. Van Stavern MD","doi":"10.1053/j.scds.2006.01.004","DOIUrl":null,"url":null,"abstract":"<div><p><span>Intracerebral hemorrhage (ICH) has an incidence of 10-20/100,000. Its most important risk factors are age, gender, race (more common in African-American, Hispanic, and Asian populations), hypertension, excessive alcohol use, and smoking. The latter two underline the importance of prevention via modification of behavior, while the value of treatment of hypertension is highlighted by clinical trial data (Perindopril Protection Against Recurrent Stroke Study [PROGRESS]) indicative of substantial risk reduction (50% relative risk reduction) by relatively modest lowering of blood pressure (by 9/4 mmHg). The importance of </span>genetic factors<span><span><span> for ICH has been recently documented, with endoglin gene insertions and </span>Factor XIII polymorphisms being associated with a significant increase in the risk of ICH. The prognosis of ICH is dependent on age, level of consciousness, hematoma volume, and intraventricular extension of hemorrhage, which are all predictors of mortality. The risk of ICH recurrence is about 2%/year overall, but with an increase to 4-5%/year if the localization is lobar. Predictors of ICH recurrence include age > 65, carrying the ϵ2 and ϵ4 alleles of the </span>apolipoprotein E<span> gene, the presence of asymptomatic microhemorrhages and leukoaraiosis. The functional outcome of ICH is poor, with only 12% of survivors being independent at 30 days.</span></span></p></div>","PeriodicalId":101154,"journal":{"name":"Seminars in Cerebrovascular Diseases and Stroke","volume":"5 3","pages":"Pages 163-167"},"PeriodicalIF":0.0000,"publicationDate":"2005-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1053/j.scds.2006.01.004","citationCount":"9","resultStr":"{\"title\":\"Primary Intracerebral Hemorrhage: Natural History, Prognosis, and Outcomes\",\"authors\":\"Renee B. Van Stavern MD\",\"doi\":\"10.1053/j.scds.2006.01.004\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p><span>Intracerebral hemorrhage (ICH) has an incidence of 10-20/100,000. Its most important risk factors are age, gender, race (more common in African-American, Hispanic, and Asian populations), hypertension, excessive alcohol use, and smoking. The latter two underline the importance of prevention via modification of behavior, while the value of treatment of hypertension is highlighted by clinical trial data (Perindopril Protection Against Recurrent Stroke Study [PROGRESS]) indicative of substantial risk reduction (50% relative risk reduction) by relatively modest lowering of blood pressure (by 9/4 mmHg). The importance of </span>genetic factors<span><span><span> for ICH has been recently documented, with endoglin gene insertions and </span>Factor XIII polymorphisms being associated with a significant increase in the risk of ICH. The prognosis of ICH is dependent on age, level of consciousness, hematoma volume, and intraventricular extension of hemorrhage, which are all predictors of mortality. The risk of ICH recurrence is about 2%/year overall, but with an increase to 4-5%/year if the localization is lobar. Predictors of ICH recurrence include age > 65, carrying the ϵ2 and ϵ4 alleles of the </span>apolipoprotein E<span> gene, the presence of asymptomatic microhemorrhages and leukoaraiosis. The functional outcome of ICH is poor, with only 12% of survivors being independent at 30 days.</span></span></p></div>\",\"PeriodicalId\":101154,\"journal\":{\"name\":\"Seminars in Cerebrovascular Diseases and Stroke\",\"volume\":\"5 3\",\"pages\":\"Pages 163-167\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2005-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1053/j.scds.2006.01.004\",\"citationCount\":\"9\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Seminars in Cerebrovascular Diseases and Stroke\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1528993106000057\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Seminars in Cerebrovascular Diseases and Stroke","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1528993106000057","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 9
摘要
脑出血(ICH)的发生率为10-20/100,000。其最重要的危险因素是年龄、性别、种族(在非裔美国人、西班牙裔和亚洲人群中更为常见)、高血压、过度饮酒和吸烟。后两者强调了通过改变行为进行预防的重要性,而临床试验数据(Perindopril Protection Against Recurrent Stroke Study [PROGRESS])强调了高血压治疗的价值,表明通过相对适度地降低血压(降低9/4 mmHg),可以显著降低风险(相对风险降低50%)。遗传因素对脑出血的重要性最近得到了证实,内啡肽基因插入和因子XIII多态性与脑出血风险的显著增加有关。脑出血的预后取决于年龄、意识水平、血肿量和脑室内出血的扩展,这些都是死亡率的预测因素。总的来说,脑出血复发的风险约为2%/年,但如果定位为大叶性,则增加到4-5%/年。脑出血复发的预测因素包括年龄> 65岁,携带载脂蛋白E基因ϵ2和ϵ4等位基因,无症状微出血和白质变的存在。脑出血的功能预后很差,只有12%的幸存者在30天内独立。
Primary Intracerebral Hemorrhage: Natural History, Prognosis, and Outcomes
Intracerebral hemorrhage (ICH) has an incidence of 10-20/100,000. Its most important risk factors are age, gender, race (more common in African-American, Hispanic, and Asian populations), hypertension, excessive alcohol use, and smoking. The latter two underline the importance of prevention via modification of behavior, while the value of treatment of hypertension is highlighted by clinical trial data (Perindopril Protection Against Recurrent Stroke Study [PROGRESS]) indicative of substantial risk reduction (50% relative risk reduction) by relatively modest lowering of blood pressure (by 9/4 mmHg). The importance of genetic factors for ICH has been recently documented, with endoglin gene insertions and Factor XIII polymorphisms being associated with a significant increase in the risk of ICH. The prognosis of ICH is dependent on age, level of consciousness, hematoma volume, and intraventricular extension of hemorrhage, which are all predictors of mortality. The risk of ICH recurrence is about 2%/year overall, but with an increase to 4-5%/year if the localization is lobar. Predictors of ICH recurrence include age > 65, carrying the ϵ2 and ϵ4 alleles of the apolipoprotein E gene, the presence of asymptomatic microhemorrhages and leukoaraiosis. The functional outcome of ICH is poor, with only 12% of survivors being independent at 30 days.